Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 142

1.

Cultivating a Research-Ready Dialysis Community.

Flythe JE, Narendra JH, Hilliard T, Frazier K, Ikeler K, Amolegbe A, Mitchell D, Dorough A, Lee SD, Ordish A, Wilkie C, Dember LM; Building Research Capacity in the Dialysis Community at the Local Level Stakeholder Workshop Participants.

J Am Soc Nephrol. 2019 Feb 8. pii: ASN.2018101059. doi: 10.1681/ASN.2018101059. [Epub ahead of print] No abstract available.

PMID:
30737271
2.

Rural patient perceptions of pharmacist-provided chronic condition management in a state with provider status.

Frazier KR, McKeirnan KC, Kherghehpoush S, Woodard LJ.

J Am Pharm Assoc (2003). 2018 Dec 18. pii: S1544-3191(18)30467-9. doi: 10.1016/j.japh.2018.10.019. [Epub ahead of print]

PMID:
30578126
3.

Pediatric oncology social workers' experience of compassion fatigue.

Yi J, Kim J, Akter J, Molloy JK, Ah Kim M, Frazier K.

J Psychosoc Oncol. 2018 Nov 19:1-14. doi: 10.1080/07347332.2018.1504850. [Epub ahead of print]

PMID:
30449270
4.

Correction to: Metabolic relevance for N-hydroxy L-arginine reduction in estrogen-negative breast cancer cells.

Mohan S, Patel S, Greenstein I, Ng C, Frazier K, Nguyen G, Harding L, Barlow D.

Amino Acids. 2018 Nov 17. doi: 10.1007/s00726-018-2680-x. [Epub ahead of print]

PMID:
30449003
5.

Circadian Clock Regulation of Hepatic Lipid Metabolism by Modulation of m6A mRNA Methylation.

Zhong X, Yu J, Frazier K, Weng X, Li Y, Cham CM, Dolan K, Zhu X, Hubert N, Tao Y, Lin F, Martinez-Guryn K, Huang Y, Wang T, Liu J, He C, Chang EB, Leone V.

Cell Rep. 2018 Nov 13;25(7):1816-1828.e4. doi: 10.1016/j.celrep.2018.10.068.

6.

Antibacterial activity of disulfiram and its metabolites.

Frazier KR, Moore JA, Long TE.

J Appl Microbiol. 2019 Jan;126(1):79-86. doi: 10.1111/jam.14094. Epub 2018 Oct 11.

PMID:
30160334
7.

Drug-induced Glomerulonephritis: The Spectre of Biotherapeutic and Antisense Oligonucleotide Immune Activation in the Kidney.

Frazier KS, Obert LA.

Toxicol Pathol. 2018 Dec;46(8):904-917. doi: 10.1177/0192623318789399. Epub 2018 Aug 8.

PMID:
30089413
8.

Toxicologic Pathology Forum Opinion Paper*: Recommendations for a Tiered Approach to Nonclinical Mechanistic Nephrotoxicity Evaluation.

Ennulat D, Ringenberg M, Frazier KS.

Toxicol Pathol. 2018 Aug;46(6):636-646. doi: 10.1177/0192623318788302. Epub 2018 Jul 26.

PMID:
30049250
9.

Teaching posterior resin composites in UK and Ireland dental schools: do current teaching programmes match the expectation of clinical practice arrangements?

Lynch CD, Blum IR, McConnell RJ, Frazier KB, Brunton PA, Wilson NHF.

Br Dent J. 2018 Jun 22;224(12):967-972. doi: 10.1038/sj.bdj.2018.446. No abstract available.

PMID:
29999043
10.

Metabolic relevance for N-hydroxy L-arginine reduction in estrogen-negative breast cancer cells.

Mohan S, Patel S, Greenstein I, Ng C, Frazier K, Nguyen G, Harding L, Barlow D.

Amino Acids. 2018 Nov;50(11):1629-1636. doi: 10.1007/s00726-018-2603-x. Epub 2018 Jun 20. Erratum in: Amino Acids. 2018 Nov 17;:.

PMID:
29922922
11.

Small Intestine Microbiota Regulate Host Digestive and Absorptive Adaptive Responses to Dietary Lipids.

Martinez-Guryn K, Hubert N, Frazier K, Urlass S, Musch MW, Ojeda P, Pierre JF, Miyoshi J, Sontag TJ, Cham CM, Reardon CA, Leone V, Chang EB.

Cell Host Microbe. 2018 Apr 11;23(4):458-469.e5. doi: 10.1016/j.chom.2018.03.011.

PMID:
29649441
12.

Disulfiram-based disulfides as narrow-spectrum antibacterial agents.

Sheppard JG, Frazier KR, Saralkar P, Hossain MF, Geldenhuys WJ, Long TE.

Bioorg Med Chem Lett. 2018 May 1;28(8):1298-1302. doi: 10.1016/j.bmcl.2018.03.023. Epub 2018 Mar 10.

PMID:
29571571
13.

Training pharmacy technicians to administer immunizations.

McKeirnan KC, Frazier KR, Nguyen M, MacLean LG.

J Am Pharm Assoc (2003). 2018 Mar - Apr;58(2):174-178.e1. doi: 10.1016/j.japh.2018.01.003. Epub 2018 Feb 16.

PMID:
29459094
14.

Moving Ahead with a New NEJM.org.

Campion EW, Scott LA, Muenning JE, Stern KL, Gartside MA, Frazier KM, Burns NS, Lawlor AJ, Prince JM, Stuart RJ, Morrissey S, Drazen JM.

N Engl J Med. 2018 Feb 8;378(6):574. doi: 10.1056/NEJMe1800731. Epub 2018 Jan 22. No abstract available.

15.

Assessing N w-hydroxy-L-arginine applicability as a novel ethnic specific estrogen-negative breast cancer marker.

Mohan S, Greenstein I, Ng C, Frazier K, Nguyen G, Harding L, Barlow D.

Amino Acids. 2018 Apr;50(3-4):373-382. doi: 10.1007/s00726-017-2523-1. Epub 2017 Dec 19.

PMID:
29260322
16.

Primary percutaneous coronary intervention at centers with and without on-site surgical support: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).

Afana M, Gurm HS, Seth M, Frazier KM, Fielding S, Koenig GC.

Am Heart J. 2018 Jan;195:99-107. doi: 10.1016/j.ahj.2017.10.004. Epub 2017 Oct 14.

PMID:
29224652
17.

ERpS294 is a biomarker of ligand or mutational ERĪ± activation and a breast cancer target for CDK2 inhibition.

Scott GK, Chu D, Kaur R, Malato J, Rothschild DE, Frazier K, Eppenberger-Castori S, Hann B, Park BH, Benz CC.

Oncotarget. 2016 Oct 18;8(48):83432-83445. doi: 10.18632/oncotarget.12735. eCollection 2017 Oct 13.

18.

Keeping Time in a Relay Race for Fat.

Frazier K, Leone V.

Cell Host Microbe. 2017 Oct 11;22(4):425-427. doi: 10.1016/j.chom.2017.09.011.

19.

Immunolesion of melanopsin neurons causes gonadal regression in Pekin drakes (Anas platyrhynchos domesticus).

Potter H, Alenciks E, Frazier K, Porter A, Fraley GS.

Gen Comp Endocrinol. 2018 Jan 15;256:16-22. doi: 10.1016/j.ygcen.2017.08.006. Epub 2017 Aug 4.

PMID:
28782536
20.

Species Differences in Renal Development and Associated Developmental Nephrotoxicity.

Frazier KS.

Birth Defects Res. 2017 Oct 2;109(16):1243-1256. doi: 10.1002/bdr2.1088. Epub 2017 Aug 2. Review.

PMID:
28766875
21.

Drug-induced Physeal Abnormalities in Preclinical Toxicity Studies.

Frazier KS.

Toxicol Pathol. 2017 Oct;45(7):869-875. doi: 10.1177/0192623317713319. Epub 2017 Jun 23. Review.

PMID:
28643552
22.

Electronic Health Records.

Frazier K.

Am J Nurs. 2017 Jun;117(6):10. doi: 10.1097/01.NAJ.0000520231.89739.11. No abstract available.

PMID:
28541967
23.

Backward compatibility effects in younger and older adults.

Hartley AA, Maquestiaux F, Festini SB, Frazier K, Krimmer PJ.

Atten Percept Psychophys. 2016 Jul;78(5):1337-50. doi: 10.3758/s13414-016-1113-8.

PMID:
27146993
24.

Increased water contamination and grow-out Pekin duck mortality when raised with water troughs compared to pin-metered water lines using a United States management system.

Schenk A, Porter AL, Alenciks E, Frazier K, Best AA, Fraley SM, Fraley GS.

Poult Sci. 2016 Apr;95(4):736-48. doi: 10.3382/ps/pev381. Epub 2016 Jan 14.

25.

Scientific and Regulatory Policy Committee Review: Review of the Organisation for Economic Co-operation and Development (OECD) Guidance on the GLP Requirements for Peer Review of Histopathology.

Fikes JD, Patrick DJ, Francke S, Frazier KS, Reindel JF, Romeike A, Spaet RH, Tomlinson L, Schafer KA; Socity of Toxicologic Pathology.

Toxicol Pathol. 2015 Oct;43(7):907-14. doi: 10.1177/0192623315596382. Epub 2015 Jul 24.

PMID:
26208968
26.

Regulatory Forum Opinion Piece*: Dispelling Confusing Pathology Terminology: Recognition and Interpretation of Selected Rodent Renal Tubule Lesions.

Seely JC, Frazier KS.

Toxicol Pathol. 2015 Jun;43(4):457-63. doi: 10.1177/0192623315573044. Epub 2015 Apr 12.

PMID:
25869578
27.

Imaging MS in Toxicology: An Investigation of Juvenile Rat Nephrotoxicity Associated with Dabrafenib Administration.

Groseclose MR, Laffan SB, Frazier KS, Hughes-Earle A, Castellino S.

J Am Soc Mass Spectrom. 2015 Jun;26(6):887-98. doi: 10.1007/s13361-015-1103-4. Epub 2015 Mar 25.

28.

Scientific and Regulatory Policy Committee Points-to-consider Paper*: Drug-induced Vascular Injury Associated with Nonsmall Molecule Therapeutics in Preclinical Development: Part I. Biotherapeutics.

Frazier KS, Engelhardt JA, Fant P, Guionaud S, Henry SP, Leach MW, Louden C, Scicchitano MS, Weaver JL, Zabka TS; Society of Toxicologic Pathology Vascular Injury Working Group.

Toxicol Pathol. 2015 Oct;43(7):915-34. doi: 10.1177/0192623315570340. Epub 2015 Feb 26. Review.

PMID:
25722122
29.

Scientific and Regulatory Policy Committee Points-to-consider Paper*: Drug-induced Vascular Injury Associated with Nonsmall Molecule Therapeutics in Preclinical Development: Part 2. Antisense Oligonucleotides.

Engelhardt JA, Fant P, Guionaud S, Henry SP, Leach MW, Louden C, Scicchitano MS, Weaver JL, Zabka TS, Frazier KS; Society of Toxicologic Pathology Vascular Injury Working Group.

Toxicol Pathol. 2015 Oct;43(7):935-44. doi: 10.1177/0192623315570341. Epub 2015 Feb 24. Review.

PMID:
25717082
30.

Parent-infant attachment.

Frazier KF, Scharf RJ.

Pediatr Rev. 2015 Jan;36(1):41-2; discussion 42. doi: 10.1542/pir.36-1-41. No abstract available.

PMID:
25554113
31.

Antisense oligonucleotide therapies: the promise and the challenges from a toxicologic pathologist's perspective.

Frazier KS.

Toxicol Pathol. 2015 Jan;43(1):78-89. doi: 10.1177/0192623314551840. Epub 2014 Nov 9. Review.

PMID:
25385330
32.

Fully-drawn carbon-based chemical sensors on organic and inorganic surfaces.

Frazier KM, Mirica KA, Walish JJ, Swager TM.

Lab Chip. 2014 Oct 21;14(20):4059-66. doi: 10.1039/c4lc00864b.

33.

Modulating the frequency and bias of stochastic switching to control phenotypic variation.

Hung M, Chang E, Hussein R, Frazier K, Shin JE, Sagawa S, Lim HN.

Nat Commun. 2014 Aug 4;5:4574. doi: 10.1038/ncomms5574.

PMID:
25087841
34.

Telotristat etiprate, a novel serotonin synthesis inhibitor, in patients with carcinoid syndrome and diarrhea not adequately controlled by octreotide.

Kulke MH, O'Dorisio T, Phan A, Bergsland E, Law L, Banks P, Freiman J, Frazier K, Jackson J, Yao JC, Kvols L, Lapuerta P, Zambrowicz B, Fleming D, Sands A.

Endocr Relat Cancer. 2014 Oct;21(5):705-14. doi: 10.1530/ERC-14-0173. Epub 2014 Jul 10.

35.

Species-specific inflammatory responses as a primary component for the development of glomerular lesions in mice and monkeys following chronic administration of a second-generation antisense oligonucleotide.

Frazier KS, Sobry C, Derr V, Adams MJ, Besten CD, De Kimpe S, Francis I, Gales TL, Haworth R, Maguire SR, Mirabile RC, Mullins D, Palate B, Doorten YP, Ridings JE, Scicchitano MS, Silvano J, Woodfine J.

Toxicol Pathol. 2014 Jul;42(5):923-35. doi: 10.1177/0192623313505781. Epub 2013 Nov 28.

PMID:
24292388
36.

Trans fat can be a hidden health risk.

Molin M, Odden N, Ha L, Henriksen TN, Frazier KS, Skarpaas A, Strand MF, Westerberg AC.

Tidsskr Nor Laegeforen. 2013 Sep 17;133(17):1844-7. doi: 10.4045/tidsskr.12.1395. English, Norwegian. No abstract available.

37.

Effects of LX4211, a dual sodium-dependent glucose cotransporters 1 and 2 inhibitor, on postprandial glucose, insulin, glucagon-like peptide 1, and peptide tyrosine tyrosine in a dose-timing study in healthy subjects.

Zambrowicz B, Ogbaa I, Frazier K, Banks P, Turnage A, Freiman J, Boehm KA, Ruff D, Powell D, Sands A.

Clin Ther. 2013 Aug;35(8):1162-1173.e8. doi: 10.1016/j.clinthera.2013.06.011. Epub 2013 Jul 31.

PMID:
23911260
38.

Robust cyclohexanone selective chemiresistors based on single-walled carbon nanotubes.

Frazier KM, Swager TM.

Anal Chem. 2013 Aug 6;85(15):7154-8. doi: 10.1021/ac400808h. Epub 2013 Jul 25.

PMID:
23886453
39.

Study design and rationale of a dose-ranging trial of LX4211, a dual inhibitor of SGLT1 and SGLT2, in type 2 diabetes inadequately controlled on metformin monotherapy.

Lapuerta P, Rosenstock J, Zambrowicz B, Powell DR, Ogbaa I, Freiman J, Cefalu WT, Banks P, Frazier K, Kelly M, Sands A.

Clin Cardiol. 2013 Jul;36(7):367-71. doi: 10.1002/clc.22125. Epub 2013 Apr 29.

40.

Agency on the move: revisioning the route to social change.

Frazier KE.

Integr Psychol Behav Sci. 2013 Sep;47(3):354-66. doi: 10.1007/s12124-013-9232-4.

PMID:
23604859
41.

Effects of LX4211, a dual SGLT1/SGLT2 inhibitor, plus sitagliptin on postprandial active GLP-1 and glycemic control in type 2 diabetes.

Zambrowicz B, Ding ZM, Ogbaa I, Frazier K, Banks P, Turnage A, Freiman J, Smith M, Ruff D, Sands A, Powell D.

Clin Ther. 2013 Mar;35(3):273-285.e7. doi: 10.1016/j.clinthera.2013.01.010. Epub 2013 Feb 21.

PMID:
23433601
42.

LX4211, a dual SGLT1/SGLT2 inhibitor, improved glycemic control in patients with type 2 diabetes in a randomized, placebo-controlled trial.

Zambrowicz B, Freiman J, Brown PM, Frazier KS, Turnage A, Bronner J, Ruff D, Shadoan M, Banks P, Mseeh F, Rawlins DB, Goodwin NC, Mabon R, Harrison BA, Wilson A, Sands A, Powell DR.

Clin Pharmacol Ther. 2012 Aug;92(2):158-69. doi: 10.1038/clpt.2012.58. Epub 2012 Jul 4.

43.

Proliferative and nonproliferative lesions of the rat and mouse urinary system.

Frazier KS, Seely JC, Hard GC, Betton G, Burnett R, Nakatsuji S, Nishikawa A, Durchfeld-Meyer B, Bube A.

Toxicol Pathol. 2012 Jun;40(4 Suppl):14S-86S. doi: 10.1177/0192623312438736.

PMID:
22637735
44.

MicroRNA changes in rat mesentery and serum associated with drug-induced vascular injury.

Thomas RA, Scicchitano MS, Mirabile RC, Chau NT, Frazier KS, Thomas HC.

Toxicol Appl Pharmacol. 2012 Aug 1;262(3):310-20. doi: 10.1016/j.taap.2012.05.009. Epub 2012 May 22.

PMID:
22627061
45.

Electrodermal responses to sources of dual-task interference.

Hartley AA, Maquestiaux F, Brooks RD, Festini SB, Frazier K.

Cogn Affect Behav Neurosci. 2012 Sep;12(3):543-56. doi: 10.3758/s13415-012-0094-x.

PMID:
22552962
46.

Reclaiming the person: intersectionality and dynamic social categories through a psychological lens.

Frazier KE.

Integr Psychol Behav Sci. 2012 Sep;46(3):380-6. doi: 10.1007/s12124-012-9198-7. Review.

PMID:
22446947
47.

Repair or replacement of defective direct resin-based composite restorations: contemporary teaching in U.S. and Canadian dental schools.

Lynch CD, Blum IR, Frazier KB, Haisch LD, Wilson NH.

J Am Dent Assoc. 2012 Feb;143(2):157-63.

PMID:
22298557
48.

Enhancing the value of operative dentistry.

Frazier K.

Oper Dent. 2011 Nov-Dec;36(6):567-71. doi: 10.2341/11-319-E. No abstract available.

PMID:
22035087
49.

Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating Cancer.

Burger MT, Pecchi S, Wagman A, Ni ZJ, Knapp M, Hendrickson T, Atallah G, Pfister K, Zhang Y, Bartulis S, Frazier K, Ng S, Smith A, Verhagen J, Haznedar J, Huh K, Iwanowicz E, Xin X, Menezes D, Merritt H, Lee I, Wiesmann M, Kaufman S, Crawford K, Chin M, Bussiere D, Shoemaker K, Zaror I, Maira SM, Voliva CF.

ACS Med Chem Lett. 2011 Aug 26;2(10):774-9. doi: 10.1021/ml200156t. eCollection 2011 Oct 13.

50.

Potential candidate genomic biomarkers of drug induced vascular injury in the rat.

Dalmas DA, Scicchitano MS, Mullins D, Hughes-Earle A, Tatsuoka K, Magid-Slav M, Frazier KS, Thomas HC.

Toxicol Appl Pharmacol. 2011 Dec 1;257(2):284-300. doi: 10.1016/j.taap.2011.09.015. Epub 2011 Sep 24.

PMID:
21983523

Supplemental Content

Loading ...
Support Center